세계의 게놈 및 단백질체학 툴 시장 보고서(2025년)

Genomic and proteomic tools comprise advanced methods and technologies used to investigate the complete set of genes (genome) and proteins (proteome) in an organism. Genomic tools analyze DNA and RNA to explore gene sequences, expression patterns, mutations, and interactions, utilizing techniques such as DNA sequencing, PCR, microarrays, and genome editing. Proteomic tools focus on protein structure, function, abundance, and interactions through methods including mass spectrometry, 2D gel electrophoresis, and protein microarrays.

The primary product categories of genomic and proteomic tools include instruments, consumables, software, and services. Instruments are specialized devices designed to measure, detect, separate, or manipulate physical or molecular properties in laboratory samples, allowing precise observation and control beyond human capabilities, covering areas from microscopy to analytical measurement. The technologies involved include sequencing, microarrays, polymerase chain reaction (PCR), and chromatography, which operate through stages of sample preparation, library preparation, data analysis, and reporting. Applications extend to drug discovery, diagnostics, personalized medicine, agriculture, and animal research.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The genomic and proteomic tool market research report is one of a series of new reports from The Business Research Company that provides genomic and proteomic tool market statistics, including genomic and proteomic tool industry global market size, regional shares, competitors with a genomic and proteomic tool market share, detailed genomic and proteomic tool market segments, market trends and opportunities, and any further data you may need to thrive in the genomic and proteomic tool industry. This genomic and proteomic tool market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genomic and proteomic tool market size has grown rapidly in recent years. It will grow from $29.63 billion in 2024 to $33.14 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth during the historic period is driven by the rising prevalence of cancer and rare diseases, expansion of academic core laboratories, increased healthcare spending in high-income countries, standardization of clinical guidelines for molecular testing, and broader reimbursement for molecular diagnostics.

The genomic and proteomic tool market size is expected to see rapid growth in the next few years. It will grow to $51.20 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The projected growth in the forecast period is supported by aging populations increasing the chronic disease burden, integration of precision medicine into national health systems, expansion of payer coverage for biomarker testing, growth in clinical trials requiring molecular stratification, and adoption of value-based care rewarding targeted therapies. Key trends in this period include advancements in long-read DNA sequencing, higher-throughput single-cell RNA sequencing, spatial co-detection of RNA and proteins in situ, digital PCR for absolute quantification, and the use of trapped ion mobility spectrometry in proteomic analysis.

The growing adoption of personalized medicine is expected to drive the expansion of the genomic and proteomic tool market. Personalized medicine involves tailoring prevention, diagnosis, and treatment based on an individual's molecular profile, which includes biomarkers derived from DNA, RNA, and proteins. This shift toward personalized approaches is largely fueled by advancements in genomics, proteomics, and biomarker discovery, which allow for treatments specifically designed around a person's genetic makeup. These innovations are boosting demand for targeted therapies, improved diagnostics, and more precise healthcare solutions. The role of genomic and proteomic tools is crucial in this process, as they help identify genetic variations and protein biomarkers, enabling clinicians to optimize treatments and enhance patient outcomes. For example, in February 2024, the Personalized Medicine Coalition and the FDA reported the approval of 16 new personalized treatments for patients with rare diseases, a significant increase from just six approvals in 2022. As a result, the rise in personalized medicine is fueling growth in the genomic and proteomic tool market.

Companies in the genomic and proteomic tools market are increasingly investing in spatial multi-omics technologies, which allow for the in-situ detection of RNA and proteins within the same cell, thereby integrating molecular data layers and preserving tissue architecture. This approach, known as spatial multi-omics, enables the measurement of gene expression and protein markers at single-cell or subcellular resolution, providing deeper biological insights than traditional single-modality tests. For instance, in August 2025, 10x Genomics, a US-based biotech company, launched Xenium Protein, a groundbreaking assay for single-cell RNA and protein analysis on the Xenium in situ platform. This solution simplifies workflows by eliminating the need for cross-platform data integration and comes with pre-validated protein subpanels for easier setup and quality control. These innovations enhance the ability to maintain spatial context while expanding biomarker panels for applications such as target validation, patient stratification, and mechanism-of-action studies.

In July 2024, Thermo Fisher Scientific Inc., a US-based biotech company, acquired Olink Holding AB to bolster its proteomics portfolio. This acquisition integrates Olink's proximity extension assay (PEA) platform into Thermo Fisher's Life Sciences Solutions segment, strengthening its capabilities in high-plex protein biomarker discovery and quantification. This acquisition complements Thermo Fisher's existing mass spectrometry and sequencing technologies and accelerates progress in translational research and the development of companion diagnostics. Olink Holding AB, a company based in Sweden, is known for its next-generation proteomics tools and solutions.

Major players in the genomic and proteomic tool market are F. HoffmannLa Roche, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc., Promega, Novogene Corp., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., Sophia Genetics, LC Sciences.

North America was the largest region in the genomic and proteomic tool market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in genomic and proteomic tool report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the genomic and proteomic tool market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomic and proteomic tool market consists of revenues earned by entities by providing services such as DNA sequencing systems, gene expression analysis platforms, microarray technologies, and mass spectrometry systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomic and proteomic tools market also includes sales of electrophoresis equipment, and chromatography instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomic And Proteomic Tool Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomic and proteomic tool market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomic and proteomic tool ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genomic and proteomic tool market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instruments; Consumables; Software; Services
• By Technology: Sequencing; Microarray; Polymerase Chain Reaction (PCR); Mass Spectrometry; Electrophoresis; Chromatography
• 3) By Workflow Stage: Sample Preparation; Library Preparation; Data Analysis; Reporting
• 4) By Application: Drug Discovery; Diagnostics; Personalized Medicine; Agriculture And Animal Research
• 5) By End User: Academic And Research Institutions; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Healthcare Providers
• Subsegments:
• 1) By Instruments: DNA Sequencing Systems; Polymerase Chain Reaction (PCR) Systems; Microarray Analyzers; Mass Spectrometry Instruments; Electrophoresis Systems; Chromatography Instruments; Flow Cytometers
• 2) By Consumables: Reagents And Kits; Assay Kits; Sample Preparation Consumables; Sequencing Consumables; Protein Assay Reagents; Microarray Chips; Laboratory Chemicals
• 3) By Software: Genomic Data Analysis Software; Proteomic Data Analysis Software; Bioinformatics Platforms; Clinical Data Interpretation Tools; Workflow Management Software; Cloud-based Analysis Platforms
• 4) By Services: Next-Generation Sequencing (NGS) Services; Gene Expression And Genotyping Services; Protein Identification And Quantification Services; Biomarker Discovery Services; Structural Biology Analysis Services; Bioinformatics And Data Interpretation Services; Molecular Diagnostics Services
• Companies Mentioned: F. HoffmannLa Roche; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Becton, Dickinson and Company; GE Healthcare; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; Bruker Corporation; Waters Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; PerkinElmer Inc.; Promega; Novogene Corp.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California, Inc.; Sophia Genetics; LC Sciences
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genomic And Proteomic Tool Market Characteristics

3. Genomic And Proteomic Tool Market Trends And Strategies

4. Genomic And Proteomic Tool Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Genomic And Proteomic Tool Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genomic And Proteomic Tool PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genomic And Proteomic Tool Market Growth Rate Analysis
• 5.4. Global Genomic And Proteomic Tool Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genomic And Proteomic Tool Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genomic And Proteomic Tool Total Addressable Market (TAM)

6. Genomic And Proteomic Tool Market Segmentation

• 6.1. Global Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Consumables
• Software
• Services
• 6.2. Global Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencing
• Microarray
• Polymerase Chain Reaction (PCR)
• Mass Spectrometry
• Electrophoresis
• Chromatography
• 6.3. Global Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Preparation
• Library Preparation
• Data Analysis
• Reporting
• 6.4. Global Genomic And Proteomic Tool Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery
• Diagnostics
• Personalized Medicine
• Agriculture And Animal Research
• 6.5. Global Genomic And Proteomic Tool Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Research Institutions
• Pharmaceutical And Biotechnology Companies
• Diagnostic Laboratories
• Healthcare Providers
• 6.6. Global Genomic And Proteomic Tool Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Sequencing Systems
• Polymerase Chain Reaction (PCR) Systems
• Microarray Analyzers
• Mass Spectrometry Instruments
• Electrophoresis Systems
• Chromatography Instruments
• Flow Cytometers
• 6.7. Global Genomic And Proteomic Tool Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Assay Kits
• Sample Preparation Consumables
• Sequencing Consumables
• Protein Assay Reagents
• Microarray Chips
• Laboratory Chemicals
• 6.8. Global Genomic And Proteomic Tool Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genomic Data Analysis Software
• Proteomic Data Analysis Software
• Bioinformatics Platforms
• Clinical Data Interpretation Tools
• Workflow Management Software
• Cloud-based Analysis Platforms
• 6.9. Global Genomic And Proteomic Tool Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing (NGS) Services
• Gene Expression And Genotyping Services
• Protein Identification And Quantification Services
• Biomarker Discovery Services
• Structural Biology Analysis Services
• Bioinformatics And Data Interpretation Services
• Molecular Diagnostics Services

7. Genomic And Proteomic Tool Market Regional And Country Analysis

• 7.1. Global Genomic And Proteomic Tool Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genomic And Proteomic Tool Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomic And Proteomic Tool Market

• 8.1. Asia-Pacific Genomic And Proteomic Tool Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomic And Proteomic Tool Market

• 9.1. China Genomic And Proteomic Tool Market Overview
• 9.2. China Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomic And Proteomic Tool Market

• 10.1. India Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomic And Proteomic Tool Market

• 11.1. Japan Genomic And Proteomic Tool Market Overview
• 11.2. Japan Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomic And Proteomic Tool Market

• 12.1. Australia Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomic And Proteomic Tool Market

• 13.1. Indonesia Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomic And Proteomic Tool Market

• 14.1. South Korea Genomic And Proteomic Tool Market Overview
• 14.2. South Korea Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomic And Proteomic Tool Market

• 15.1. Western Europe Genomic And Proteomic Tool Market Overview
• 15.2. Western Europe Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomic And Proteomic Tool Market

• 16.1. UK Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomic And Proteomic Tool Market

• 17.1. Germany Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomic And Proteomic Tool Market

• 18.1. France Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomic And Proteomic Tool Market

• 19.1. Italy Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomic And Proteomic Tool Market

• 20.1. Spain Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomic And Proteomic Tool Market

• 21.1. Eastern Europe Genomic And Proteomic Tool Market Overview
• 21.2. Eastern Europe Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomic And Proteomic Tool Market

• 22.1. Russia Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomic And Proteomic Tool Market

• 23.1. North America Genomic And Proteomic Tool Market Overview
• 23.2. North America Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomic And Proteomic Tool Market

• 24.1. USA Genomic And Proteomic Tool Market Overview
• 24.2. USA Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomic And Proteomic Tool Market

• 25.1. Canada Genomic And Proteomic Tool Market Overview
• 25.2. Canada Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomic And Proteomic Tool Market

• 26.1. South America Genomic And Proteomic Tool Market Overview
• 26.2. South America Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomic And Proteomic Tool Market

• 27.1. Brazil Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomic And Proteomic Tool Market

• 28.1. Middle East Genomic And Proteomic Tool Market Overview
• 28.2. Middle East Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomic And Proteomic Tool Market

• 29.1. Africa Genomic And Proteomic Tool Market Overview
• 29.2. Africa Genomic And Proteomic Tool Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genomic And Proteomic Tool Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genomic And Proteomic Tool Market, Segmentation By Workflow Stage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomic And Proteomic Tool Market Competitive Landscape And Company Profiles

• 30.1. Genomic And Proteomic Tool Market Competitive Landscape
• 30.2. Genomic And Proteomic Tool Market Company Profiles
  • 30.2.1. F. HoffmannLa Roche Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Genomic And Proteomic Tool Market Other Major And Innovative Companies

• 31.1. GE Healthcare
• 31.2. Eurofins Scientific SE
• 31.3. Agilent Technologies Inc.
• 31.4. Illumina Inc.
• 31.5. Bruker Corporation
• 31.6. Waters Corporation
• 31.7. Bio-Rad Laboratories Inc.
• 31.8. QIAGEN N.V.
• 31.9. PerkinElmer Inc.
• 31.10. Promega
• 31.11. Novogene Corp.
• 31.12. Oxford Nanopore Technologies Ltd.
• 31.13. Pacific Biosciences of California, Inc.
• 31.14. Sophia Genetics
• 31.15. LC Sciences

32. Global Genomic And Proteomic Tool Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomic And Proteomic Tool Market

34. Recent Developments In The Genomic And Proteomic Tool Market

35. Genomic And Proteomic Tool Market High Potential Countries, Segments and Strategies

• 35.1 Genomic And Proteomic Tool Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genomic And Proteomic Tool Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genomic And Proteomic Tool Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer